Literature DB >> 4506296

Antigen solubilized from human leukemia: lymphocyte stimulation.

J U Gutterman, G Mavligit, K B McCredie, G P Bodey, E J Freireich, E M Hersh.   

Abstract

Soluble antigen was extracted with hypertonic (3 molar) potassium chloride from the malignant cells of seven patients with acute leukemia. The antigen and leukemia cells were used to stimulate autologous patients' and allogeneic normal donors' lymphocytes in mixed lymphocyte cultures. The lymphocytes of six patients showed significant blastogenic responses to autologous antigen. In contrast, the lymphocytes of only one of seven normal donors responded to the soluble antigens. Both patients' and normal subjects' lymphocytes responded to the intact leukemia cells. The use of these antigens should facilitate the study of specific tumor immunity in human leukemia.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4506296     DOI: 10.1126/science.177.4054.1114

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

Authors:  H Yamasaki; E Okamoto; T Komatsu; Y Manabe; S Shinka
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

Authors:  H L Jenssen; H Köhler; J Günther; B Klausch; W Straube; R Hofmann; H H Büttner
Journal:  Arch Gynakol       Date:  1976-03-05

3.  Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas.

Authors:  P Koldovsky; U Koldovsky; J Ebbers; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1986

4.  A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues.

Authors:  J P Dickinson; J R McDermott; J K Smith; E A Caspary
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640

5.  Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.

Authors:  S G Gangal; B P Gothoskar; C S Joshi; S H Advani
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

6.  Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.

Authors:  J T Frbes; Y Nakaw; R T Smith
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

7.  The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma.

Authors:  R D Watson; A G Smith; J G Levy
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

8.  Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.

Authors:  M B Calderwood; J T Forbes; R T Smith
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

9.  Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

Authors:  G M Taylor; C B Freeman; R Harris
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.